Cargando…
Paradoxical SAPHO Syndrome after Etanercept in a Patient with Psoriasis
Autores principales: | Gimeno-Castillo, Javier., Rosés-Gibert, Pau., Parrón, Aida. Menéndez, de la Torre Gomar, Francisco J., de Lagrán-Álvarez de Arcaya, Zuriñe. Martínez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043700/ https://www.ncbi.nlm.nih.gov/pubmed/36998866 http://dx.doi.org/10.4103/ijd.ijd_353_22 |
Ejemplares similares
-
Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain
por: Rosés-Gibert, Pau, et al.
Publicado: (2020) -
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
por: Rosés Gibert, Pau, et al.
Publicado: (2022) -
Sacroiliitis and Spondylitis with Sternoclavicular Hyperostosis: SAPHO or an Ankylosing Spondylitis Variant?
por: Shen, Kai, et al.
Publicado: (2016) -
A Case of Cutaneous T-cell Lymphoma, Masquerading as Psoriasis, Was Given Etanercept and Secukinumab: Emphasizing the Need for Biopsy Confirmation before Starting Biologics
por: De, Abhishek, et al.
Publicado: (2017) -
Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)